Microcirculatory disturbances – relationship with peripheral vascular reactivity and structure-functional properties of endothelium in systemic sclerosis
https://doi.org/10.14412/1995-4484-2009-1147
Abstract
Microcirculatory disturbances – relationship with peripheral vascular reactivity and structure- functional properties of endothelium in systemic sclerosis. Objective. To assess basal capillary blood flow and examine degree of microcirculatory disturbances depending on plasma endothelin 1 content and structure-functional status of endothelium in pts with systemic sclerosis (SS). Material and methods. 31 pts with SS (31 female and 3 male) with mean age 48±2,1 years and disease duration 9,9±1,3 years and 15 healthy persons match on age and sex were included. Laser Doppler flowmetry, assessment of plasma endothelin-1 (ET1), peripheral blood circulating endothelial cells (CEC), endothelium-dependent (EDVD) and endothelium-independent vasodilatation (EIVD) was performed. Results. All pts with SS had decrease of capillary perfusion and disturbance of peripheral vessel reactivity in comparison with healthy persons. Microcirculatory disorders intensity in SS was shown to depend on plasma ET1 level. Basal values of ET1 concentration were significantly higher in comparison with control group. Peripheral microcirculation measures tightly correlated with plasma ET1 and CEC what point to systemic character of capillary blood flow disturbances in SS. Conclusion. Microcirculatory disorders intensity in SS depends on degree of structure-functional endothelium changes on peripheral and systemic vessel levels.
References
1. <div><p>Krieg T, Hunzelmann N, Gabrielli A, Jablonska S. Scleroderma. Eur. J. Dermatol., 2008, 18, 213-4.</p><p>Dorffler-Melly J, Luscher TF, Wenk M., et al. Endothelin-1 and cold provocation in health, primary Raynaud’s phenomenon, and progressive systemic sclerosis. Microvasc. Res., 1996, 52, 193-7.</p><p>Rubens C, Ewert R, Halank M., et al. Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest, 2001, 120, 1562-9.</p><p>Abraham DJ, Vancheeswaran R, Dashwood MR., et al. Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease. Am. J. Pathol., 1997, 151, 831-41.</p><p>Dooley A, Gao B, Bradley N., et al. Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine. Rheumatology (Oxford), 2006, 45, 676-84.</p><p>Dooley A, Gao B, Shi-Wen X., et al. Effect of nitric oxide and peroxynitrite on type I collagen synthesis in normal and scleroderma dermal fibroblasts. Free Radic. Biol. Med., 2007, 43, 253-64.</p><p>Mukerjee D, Yap LB, Ong V., et al. The myth of pulmonary Raynaud‘s phenomenon: the contribution of pulmonary arterial vasospasm in patients with systemic sclerosis related pulmonary arterial hypertension. Ann. Rheum. Dis., 2004, 63, 1627-31.</p><p>Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum., 1980, 23, 581-90.</p><p>Rushentsova U, Opazo Saez AM, Mosel F., et al. Laser Doppler imager (LDI) scanner and intradermal injection for in vivo pharmacology in human skin microcirculation: responses to acetylcholine, endothelin-1 and their repeatability. Br. J. Clin. Pharmacol., 2005, 59, 511-9.</p><p>Anderson ME, Hollis S, Moore T., et al. Non-invasive assessment of vascular reactivity in forearm skin of patients with primary Raynaud’s phenomenon and systemic sclerosis. Br. J. Rheumatol., 1996, 35, 1281-8.</p><p>Kubli S, Waeber B, Dalle-Ave A, Feihl F: Reproducibility of laser Doppler imaging of skin blood flow as a tool to assess endothelial function. J. Cardiovasc. Pharmacol., 2000, 36, 640-8.</p><p>Herrick AL. Pathogenesis of Raynaud’s phenomenon. Rheumatology (Oxford), 2005, 44, 587-96.</p><p>Suschek CV, Schnorr O, Kolb-Bachofen V. The role of iNOS in chronic inflammatory processes in vivo: is it damage-promoting, protective, or active at all? Curr. Mol. Med., 2004, 4, 763-75.</p><p>Mitchell A, Rushentsova U, Siffert W., et al. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism. Clin. Pharmacol. Ther., 2006, 79, 274-81.</p><p>Rushentsova U, Detmer N, Mitchell A, Philipp T. Effects of ET-1 antagonism on ET-1-mediated vasoconstriction in the skin microcirculation in man in vivo. J. Hypertension, 2006, 24(4), 207-10.</p><p>Sunderkotter C, Riemekasten G: Pathophysiology and clinical consequences of Raynaud’s phenomenon related to systemic sclerosis. Rheumatology (Oxford), 2006, 45, suppl 3:iii33-iii35.</p></div><br />
Review
For citations:
Ruzentsova U.Y. Microcirculatory disturbances – relationship with peripheral vascular reactivity and structure-functional properties of endothelium in systemic sclerosis. Rheumatology Science and Practice. 2009;47(4):26-31. (In Russ.) https://doi.org/10.14412/1995-4484-2009-1147
Views:
1978
Email this article 